Trials / Completed
CompletedNCT00857441
Drug-eluting Balloon in Bifurcations Trial
A Prospective Three-arm Multi-center Study to Investigate Procedural, Clinical and Angiographic Outcomes Using a Drug Eluting Balloon Versus a Standard Balloon in Combination With a Bare Metal Stent and a DES Stent, Following the Provisional Side Branch T-stenting Approach, in Patients With Complex Lesions
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- UMC Utrecht · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the DEBIUT study is to assess procedural, clinical and angiographic outcomes of: 1. Provisional T-stenting use for dilation the Paclitaxel-eluting PCI-balloon (DiorTM) in comparison to dilation with a standard balloon prior to the implant of the Liberty Bare Metal Stent in bifurcation lesions (with side branch involvement). 2. Comparison of the results above with the results of using a standard balloon prior to provisional T-stenting with the Paclitaxel-eluting stent TaxusTM LibertéTM.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Drug eluting balloon | Percutaneous transluminal coronary balloon angioplasty catheter eluting paclitaxel |
| DEVICE | Liberté | Bare metal stent |
| DEVICE | PTCA balloon catheter | Percutaneous transluminal coronary angioplasty catheter |
| DEVICE | Taxus | Paclitaxel eluting stent |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2009-09-01
- Completion
- 2015-01-01
- First posted
- 2009-03-06
- Last updated
- 2015-07-20
Locations
3 sites across 2 countries: Belgium, Netherlands
Source: ClinicalTrials.gov record NCT00857441. Inclusion in this directory is not an endorsement.